LLIN Evaluation in Uganda Project (LLINEUP3)
Study Details
Study Description
Brief Summary
In Uganda, the National Malaria Control Division (NMCD) and implementing partners are planning to deliver long-lasting insecticidal nets (LLINs) nationwide, through a mass distribution campaign in 2023. LLINs will be distributed free-of-charge to all Ugandan households, aiming to achieve universal coverage. LLINs treated with a pyrethroid insecticide plus chlorfenapyr (PermaNet Dual, Vestergaard) and LLINs treated with a pyrethroid insecticide plus PBO (PermaNet 3.0, Vestergaard) will be distributed as part of this distribution campaign, presenting an opportunity to rigorously evaluate and compare these two LLINs at scale across Uganda. In collaboration with the MOH, this cluster-randomised trial will compare the impact of LLINs combining chlorfenapyr with a pyrethroid to LLINs combining PBO with a pyrethroid into Uganda's 2023 LLIN distribution campaign, as was done successfully at the time of the last LLIN distribution campaign conducted in 2020-21. A major strength of this trial is the use of malaria incidence as the primary outcome measure. Incidence of malaria, defined as the number of symptomatic cases of malaria occurring in a population at risk over time, is the gold standard for assessing malaria burden. However, cluster-randomised trials using malaria incidence as the primary outcome typically involve study cohorts and are very expensive and logistically challenging. The novel approach for measuring malaria incidence is to utilize data collected routinely at health facilities. By defining target areas around health facilities and collecting data on the location of residence of patients diagnosed with malaria, this study will be able to generate longitudinal measures of malaria incidence at an unprecedented scale across Uganda as done in the LLINEUP2 trial (NCT04566510). These results will inform policies and programmes for malaria and potentially provide evidence to support widescale deployment of dual AI chlorfenapyr-pyrethroid LLINs. This study, the first evaluating PermaNet Dual LLINs, will also provide evidence for a second in class chlorfenapyr net, a potential tool to be added to the malaria control tool kit.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
This is a cluster-randomised trial to evaluate the impact of long-lasting insecticidal nets (LLINs) distributed in Uganda through the 2023 national universal coverage campaign. A cluster has been defined as the target area surrounding an MRC. A total of 24 clusters will be included in the study, covering 20 moderate-high malaria burden districts in Uganda. Clusters have been randomised in a 1:1 ratio to receive one of two types of LLINs: (1) chlorfenapyr-pyrethroid LLINs (PermaNet Dual, n=12) or (2) PBO-pyrethroid LLINs (PermaNet 3.0, n=12). The intervention, including delivery of the LLINs and social and behaviour change communication (SBCC), will be led by the Ugandan NMCD and other stakeholders. Currently, LLINs are scheduled to be distributed in the study areas during waves 5 and 6 from September to October 2023 as part of the national LLIN distribution campaign. The evaluation of the intervention will include: 1) health facility surveillance at the participating MRCs to generate continuous estimates of malaria incidence for each MRC target area; 2) cross-sectional community surveys at 12- and 24-months post-LLIN distribution to gather information on parasite prevalence, anaemia prevalence, net ownership, coverage, and use, 3) entomology surveys at 12 and 24 months to gather information on vector density. The primary outcome of the trial will be malaria incidence as estimated using the health facility surveillance.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: PermaNet Dual long lasting insecticidal nets with chlorfenapyr-pyrethroid |
Other: long lasting insecticidal nets with chlorfenapyr-pyrethroid (PermaNet Dual)
Next-generation bed net combining insecticides with different modes of action
Behavioral: Social Behavior Change Communication
The NMCD and other stakeholders will take the lead on Social Behaviour Change Communication (SBCC). SBCC activities will use digital and other platforms, including the following: (1) LLIN launch at the World Malaria Day celebrations; (2) regional in-person advocacy meetings; (3) mass media platforms (for advertisements, mini skits, DJ mentions, radio spots, interactive talks); (4) social media platforms; (5) VHTs; (6) operation hotlines and toll-free call centres; (7) community mobilisation (megaphones); and (8) use of appropriate information, education, and communication materials. Communication will include messages about malaria, and use, care, repair and repurposing of bed nets.
|
| Active Comparator: PermaNet 3.0 long lasting insecticidal nets with PBO-pyrethroid |
Other: long lasting insecticidal nets with PBO-pyrethroid (PermaNet)
Next-generation bed net combining an insecticide with a synergist
Behavioral: Social Behavior Change Communication
The NMCD and other stakeholders will take the lead on Social Behaviour Change Communication (SBCC). SBCC activities will use digital and other platforms, including the following: (1) LLIN launch at the World Malaria Day celebrations; (2) regional in-person advocacy meetings; (3) mass media platforms (for advertisements, mini skits, DJ mentions, radio spots, interactive talks); (4) social media platforms; (5) VHTs; (6) operation hotlines and toll-free call centres; (7) community mobilisation (megaphones); and (8) use of appropriate information, education, and communication materials. Communication will include messages about malaria, and use, care, repair and repurposing of bed nets.
|
Outcome Measures
Primary Outcome Measures
- Number of cases of laboratory-confirmed malaria diagnosed at the MRC among patients residing in the target area [24-months follow up]
malaria incidence: number of cases divided by the total population of the target area
Secondary Outcome Measures
- Prevalence of parasitaemia [24-months following LLIN distribution]
Proportion of blood smears positive for parasites by microscopy in individuals of all ages at the time of cross-sectional surveys
- Prevalence of anemia [24-months following LLIN distribution]
Proportion of children aged 2-4 years with haemoglobin < 11 g/dL at the time of cross-sectional surveys
- Proportion of households that owned at least one LLIN [24-months following LLIN distribution]
Proportion of households with at least one LLIN at the time of cross-sectional surveys
- Proportion of households that owned at least one LLIN for every two occupants [24-months following LLIN distribution]
Proportion of households with at least one LLIN per every two occupants at the time of cross-sectional surveys
- Proportion of household residents who slept under an LLIN the previous night [24-months following LLIN distribution]
Proportion of households residents who report sleeping under LLIN the previous night at the time of cross-sectional surveys
- Number of female anopheles mosquitoes collected per household at the time of cross-sectional surveys [24-months following LLIN distribution]
Vector density
Eligibility Criteria
Criteria
Household Survey
Inclusion Criteria:
-
At least one adult aged 18 years or older present
-
Adult is a usual resident who slept in the sampled household on the night before the survey
-
Agreement of the adult resident to provide informed consent for the household and entomology survey
Exclusion Criteria:
-
Dwelling destroyed or not found
-
Household vacant
-
No adult resident home on more than 3 occasions
Clinical Survey
Inclusion Criteria:
-
Usual resident who was present in the sampled household on the night before the survey
-
Agreement of adult or parent/guardian (of children) to provide informed consent
-
Agreement of child aged 8 years or older to provide assent
Exclusion Criteria:
- Resident not home on day of survey
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Infectious Diseases Research Collaboration | Kampala | Uganda |
Sponsors and Collaborators
- University of California, San Francisco
- National Institute of Allergy and Infectious Diseases (NIAID)
- Infectious Diseases Research Collaboration, Uganda
- Ministry of Health, Uganda
- Against Malaria Foundation
- Liverpool School of Tropical Medicine
Investigators
- Principal Investigator: Moses Kamya, MBChB, MMed, PhD, Makerere University; Infectious Diseases Research Collaboration
- Principal Investigator: Grant Dorsey, MD, PhD, University of California, San Francisco
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LLINEUP3
- U19AI089674